Equities research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued on Wednesday. The firm set a “buy” rating on the stock.
Mannatech Trading Up 0.4 %
NASDAQ:MTEX opened at $7.50 on Wednesday. The company has a market capitalization of $14.14 million, a P/E ratio of -8.43 and a beta of 1.17. The stock’s 50 day moving average price is $7.44 and its 200 day moving average price is $7.63. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. Mannatech has a 52 week low of $6.75 and a 52 week high of $10.51.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The business had revenue of $27.74 million for the quarter.
Insider Activity at Mannatech
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- How to Start Investing in Real Estate
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- What is the FTSE 100 index?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.